Industry Group Calls for Revocation of Interim Health Claims Rules
This article was originally published in The Tan Sheet
Executive Summary
FDA's nine interim final rules barring proposed health claims should be revoked and the claims authorized, Weider Nutrition, Pure Encapsulations, the American Preventive Medical Association, Shari Lieberman, PhD, and Julian Whitaker, MD, assert in joint comments submitted to the agency Sept. 8.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning